/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Amarin Corp PLC Share Price Today: Live Updates & Key Insights

Amarin Corp PLC share price today is $16.37, up 0.31%. The stock opened at $16.12 against the previous close of $16.32, with an intraday high of $16.95 and low of $16.12.

Amarin Corp PLC Share Price Chart

style
pb-0

Amarin Corp PLC

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Amarin Corp PLC Share Price Performance

$16.37 0.0031(0.31%) AMRN at 13 Mar 2026 11:59 AM Drug Manufacturers - General
Lowest Today 16.12
Highest Today 16.95
Today’s Open 16.12
Prev. Close 16.32
52 Week High 20.90
52 Week Low 7.60
Day’s Range: Low 16.12 High 16.95
52-Week Range: Low 7.60 High 20.90
1 day return -
1 Week return +16.01
1 month return +10.13
3 month return +15.35
6 month return +9.61
1 year return +3885.33
3 year return +951.61
5 year return +147.9
10 year return -

Amarin Corp PLC Institutional Holdings

Sarissa Capital Management LP 8.04

Acadian Asset Management LLC 2.19

Kynam Capital Management, LP 1.87

Morgan Stanley - Brokerage Accounts 1.30

Eversept Partners, LP 0.80

Waterfront Wealth Inc. 0.69

Millennium Management LLC 0.64

Citadel Advisors Llc 0.59

Two Sigma Investments LLC 0.53

BNP Paribas Arbitrage, SA 0.50

SCP Investment, LP 0.48

Susquehanna International Group, LLP 0.39

Quinn Opportunity Partners LLC 0.28

Old Westbury Small & Mid Cap Strategies 0.27

Waterfront OS 0.26

JPMorgan Chase & Co 0.21

LCM Capital Management, Inc 0.20

Waterfront OE 0.18

Two Sigma Advisers, LLC 0.18

SEI Investments Co 0.14

Jane Street Group LLC 0.13

Jump Financial LLC 0.13

Hayek Kallen Investment Management 0.12

State Street® SPDR® Ptf Dev Wld exUS ETF 0.08

SEI International Equity F (SIT) 0.07

Fidelity Nasdaq Composite Index 0.06

Voya Multi-Manager International Sm Cp A 0.05

Nomura Healthcare Fund Class I 0.05

State Street® SPDR® S&P® Intl Sm Cp ETF 0.04

Acadian European SmCp Eq C2-i-0.7500-EUR 0.02

China Universal NASDAQ Bio-Tch ETF(QDII) 0.02

Hector SICAV FIDE Growth 0.02

Steward Values Enhanced International I 0.01

AVIP BlackRock Advtg Small Cp Gr Prtfl 0.00

Blackstone Alternative Multi-Strategy I 0.00

ST Dorsey Wright® Intl Momntm Tr 40 CA 0.00

ST Dorsey Wright® Intl Momntm Tr 41 CA 0.00

Amarin Corp PLC Market Status

Strong Buy: 0

Buy: 0

Hold: 1

Sell: 2

Strong Sell: 0

Amarin Corp PLC Fundamentals

Market Cap 339.52 M

PB Ratio 0.7392

PE Ratio 0.0

Enterprise Value 43.01 M

Total Assets 670.77 M

Volume 126744

Amarin Corp PLC Company Financials

Annual Revenue FY25:182753000 182.8M, FY23:322443000 322.4M, FY22:369193000 369.2M, FY21:583187000 583.2M, FY20:614060000 614.1M

Annual Profit FY25:120868000 120.9M, FY23:184021000 184.0M, FY22:242484000 242.5M, FY21:461860000 461.9M, FY20:482616000 482.6M

Annual Net worth FY25:-38798000 -38.8M, FY23:-52475000 -52.5M, FY22:-105803000 -105.8M, FY21:7729000 7.7M, FY20:-18000000 -18.0M

Quarterly Revenue Q4/2025:19437000 19.4M, Q3/2025:49670000 49.7M, Q2/2025:72741000 72.7M, Q1/2025:42017000 42.0M, Q3/2024:42298000 42.3M

Quarterly Profit Q4/2025:23169000 23.2M, Q3/2025:22208000 22.2M, Q2/2025:50362000 50.4M, Q1/2025:25130000 25.1M, Q3/2024:16276000 16.3M

Quarterly Net worth Q4/2025:-1224000 -1.2M, Q3/2025:-7738000 -7.7M, Q2/2025:-14139000 -14.1M, Q1/2025:-15697000 -15.7M, Q3/2024:-25134000 -25.1M

About Amarin Corp PLC & investment objective

Company Information Amarin Corporation plc, a pharmaceutical company, engages in the commercialization and development of therapeutics for the treatment of cardiovascular diseases in the United States, Europe, and internationally. It offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. The company sells its products principally through wholesalers, selected regional wholesalers, and retail and mail order pharmacy providers. It has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa, the omega-3 acid, EPA. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.

Organisation Drug Manufacturers - General

Employees 80

Industry Drug Manufacturers - General

CEO Mr. Aaron D. Berg

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow